News - Pharmaceutical
Pharmaceutical export increases 0.37% in last five months
8 January 2013
ISLAMABAD - The export of pharmaceutical products from the country during the last five months of current financial year witnessed growth of 0.37 percent as compared to same period of last year. During the period from July-November 2012 about 6,989 ...
Click on the link to read the full article at PakistanToday.com.pk (This link will open in a new window)Marken Opens Expanded Pharmaceutical Depot in Mexico City
8 January 2013
8, 2013 /PRNewswire/ -- Marken announced today the completion of its new, expanded pharmaceutical depot in Mexico City. The new state of the art facility is located closer to the Mexico City airport and provides a total of 1300 m
Click on the link to read the full article at PharmaLive (press release) (subscription) (This link will open in a new window)CHUGAI PHARMACEUTICAL CO., LTD. : Chugai and Debiopharm ...
8 January 2013
January 8, 2013 (Tokyo) - Chugai Pharmaceutical Co., Ltd. ("Chugai") and Debiopharm GroupTM ("Debiopharm") announced today that on December 17, 2012, they entered into a licensing agreement regarding FF284 (called Debio 1347 by Debiopharm) ...
Click on the link to read the full article at 4-traders (This link will open in a new window)Malaysia an Asean hub for Indian pharmaceutical companies
8 January 2013
NEW DELHI: Malaysia is fast emerging as a major manufacturing hub for Indian pharmaceutical companies, especially for exports to South-East Asian countries. Big names such as Ranbaxy, Cipla, Dr Reddy's Labs, Biocon and Strides Arcolab have started ...
Click on the link to read the full article at The Star Online (This link will open in a new window)Kinex Pharmaceuticals and Hanmi Pharmaceutical Announce First Patient has ...
7 January 2013
7, 2013 /PRNewswire/ -- Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the first patient has been enrolled in Hanmi's Phase Ib / IIa clinical trial in Korea. Kinex's dual Src/pretubulin Inhibitor, KX01, is being combined with ...
Click on the link to read the full article at PharmaLive (press release) (subscription) (This link will open in a new window)Peregrine Pharmaceutical's Big Jump
7 January 2013
(More...) Just this morning, Peregrine Pharmaceuticals (NASDAQ:PPHM) put out a press release and provided an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second ...
Click on the link to read the full article at Seeking Alpha (This link will open in a new window)Opinion: When it comes to pharmaceutical research, Canada is missing out
7 January 2013
Canada is a strong nation economically, with a $1.7-trillion gross domestic product and spending on research and development in excess of $30 billion annually. By any measure these numbers are among the best in the world. But pharmaceutical research ...
Click on the link to read the full article at Montreal Gazette (This link will open in a new window)Tranzyme completes drug discovery partnership with Bristol-Myers
7 January 2013
Select a Pharmaceutical sector, ------------------------, Fine & Speciality Chemicals, Manufacturing, Process & Production, OTC, ------------------------, Drug Delivery, Drug Discovery & Development, ------------------------, Clinical Trials, Contract ...
Click on the link to read the full article at Pharmaceutical Business Review (This link will open in a new window)Malaysia fast-emerging pharmaceutical hub
7 January 2013
Malaysia is fast emerging as a major manufacturing hub for Indian pharmaceutical companies, especially for exports to Southeast Asian countries. Big names such Ranbaxy, Cipla, Dr Reddy's Labs, Biocon and Strides Arcolab have started operations there, ...
Click on the link to read the full article at Business Times - Malaysia (This link will open in a new window)Scandal Surrounding French Diet Pill Widens as Pharmaceutical Chief Is ...
6 January 2013
A troubling new development in a long-running pharmaceutical scandal in France has people wondering just how much power drug companies wield in the country. The Guardian's Angelique Chrisafis reports that victims of a controversial (read: fucking ...
Click on the link to read the full article at Jezebel (This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
